QT
ORMP icon

Quantbot Technologies’s Oramed Pharmaceuticals ORMP Stock Holding History

Quantbot Technologies’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,300
Closed -$5.31K – 1831
2023
Q4 		$5.31K Buy
2,300
+1,369
+147% +$2.92K ﹤0.01% 1489
2023
Q3 		$2.43K Buy
+931
New +$2.93K ﹤0.01% 1466
2022
Q3 		– Sell
-742
Closed -$3K – 1955
2022
Q2 		$3K Buy
+742
New +$3.96K ﹤0.01% 1610

Other funds holding ORMP

M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $25B AUM 18.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Quantbot Technologies's ORMP Position: Q1 2024 in Review

Quantbot Technologies sold out of Oramed Pharmaceuticals (ORMP) in Q1 2024, closing a stake of 2,300 shares — an estimated $5.31K sold.

Quantbot Technologies first reported a position in ORMP in Q2 2022 and held it in 3 quarters. The position peaked at $5.31K in Q4 2023. 51 funds tracked by Wall St. Rank hold ORMP as of Q1 2024.

  • Quantbot Technologies reported no remaining Oramed Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Quantbot Technologies sold 2,300 Oramed Pharmaceuticals shares in Q1 2024, an estimated $5.31K.
  • Quantbot Technologies first reported a position in Oramed Pharmaceuticals in Q2 2022 and held it in 3 quarters.
  • Quantbot Technologies's Oramed Pharmaceuticals position peaked at $5.31K in Q4 2023.
  • 51 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q1 2024.

Based on Quantbot Technologies's 13F filing for Q1 2024, filed 6 May 2024.